POLXF
Polydex Pharmaceuticals Ltd
Price:  
1.99 
USD
Volume:  
2,990
Canada | Pharmaceuticals

POLXF DCF Valuation - Growth Exit 5Y

-18.3 %
Upside

What is the DCF valuation of POLXF?

The Discounted Cash Flow (DCF) valuation of Polydex Pharmaceuticals Ltd (POLXF) is 1.62 USD. With the latest stock price at 1.99 USD, the upside of Polydex Pharmaceuticals Ltd based on DCF is -18.3%.

Is POLXF a buy or a sell?

Based on the latest price of 1.99 USD and our DCF valuation, Polydex Pharmaceuticals Ltd (POLXF) is a sell. Selling POLXF stocks now will result in a potential gain of 18.3%.

Range Selected
WACC / Discount Rate5.3% - 6.6%5.9%
Long-term Growth Rate 0.0% - 1.0%0.5%
Fair Price1.38 - 1.991.62
Upside-30.4% - 0.1%-18.3%
1.99 USD
Stock Price
1.62 USD
Fair Price
REVENUE & EXPENSES
CAPEX
D&A
WORKING CAPITAL
TERMINAL VALUE

POLXF DCF Valuation: Revenue & Expenses Forecast

(USD in millions)Projections
01-202101-202201-202301-202401-202501-2026
Revenue555566
% Growth
6%-1%4%2%9%4%
Cost of goods sold(4)(4)(4)(4)(4)(5)
% of Revenue80%80%80%80%80%80%
Selling, G&A expenses(1)(1)(1)(1)(1)(1)
% of Revenue13%13%13%13%13%13%
Research & Development000000
% of Revenue0%0%0%0%0%0%
Net interest & other expenses(0)(0)(0)(0)(0)(0)
% of Revenue3%3%3%3%3%3%
Tax expense0(0)(0)(0)(0)(0)
Tax rate1%7%7%7%7%7%
Net profit000000
% Margin4%4%4%4%4%4%